75 related articles for article (PubMed ID: 118786)
1. [A chemical structure in tuberculous bacilli responsible for epithelioid granuloma formation (proceedings)].
Emori K; Tanaka A
Bull Int Union Tuberc; 1979 Jun; 54(2):176. PubMed ID: 118786
[No Abstract] [Full Text] [Related]
2. [Pathology of epithelioid cell granulomas in relation to the cell components of Mycobacterium tuberculosis].
Morikawa K; Okuyama H; Okabe M; Yasumizu Y; Azuma I
Kekkaku; 1979 Oct; 54(10):504-6. PubMed ID: 119086
[No Abstract] [Full Text] [Related]
3. [Epithelioid granuloma formation by a bacterial cell wall constituent. (Part 2)].
Tanaka A
Kekkaku; 1983 Jan; 58(1):39-51. PubMed ID: 6405070
[No Abstract] [Full Text] [Related]
4. [Induction of epithelioid cell granulomas by muramyl dipeptide].
Tanaka A; Emori K; Nagao S
Kekkaku; 1979 Oct; 54(10):503-4. PubMed ID: 529659
[No Abstract] [Full Text] [Related]
5. Epithelioid granuloma formation by a synthetic bacterial cell wall component, muramyl dipeptide (MDP).
Tanaka A; Emori K
Am J Pathol; 1980 Mar; 98(3):733-48. PubMed ID: 6767407
[TBL] [Abstract][Full Text] [Related]
6. Granuloma formation by muramyl dipeptide associated with branched fatty acids, a structure probably essential for tubercle formation by Mycobacterium tuberculosis.
Emori K; Nagao S; Shigematsu N; Kotani S; Tsujimoto M; Shiba T; Kusumoto S; Tanaka A
Infect Immun; 1985 Jul; 49(1):244-9. PubMed ID: 3924828
[TBL] [Abstract][Full Text] [Related]
7. [Epithelioid granuloma formation by a bacterial cell wall constituent. (Part 1)].
Tanaka A
Kekkaku; 1982 Dec; 57(12):671-86. PubMed ID: 7182646
[No Abstract] [Full Text] [Related]
8. Relationship of anti-tuberculous protection to lung granuloma produced by intravenous injection of synthetic 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with or without specific antigens.
Yamamoto K; Kakinuma M; Kato K; Okuyama H; Azuma I
Immunology; 1980 Aug; 40(4):557-64. PubMed ID: 7000685
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of IgE antibody formation by tubercle bacilli and muramyl peptide].
Kishimoto T
Kekkaku; 1980 Oct; 55(10):467-70. PubMed ID: 6785511
[No Abstract] [Full Text] [Related]
10. Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide.
Emori K; Tanaka A
Infect Immun; 1978 Feb; 19(2):613-20. PubMed ID: 75847
[TBL] [Abstract][Full Text] [Related]
11. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
[TBL] [Abstract][Full Text] [Related]
12. Muramyl dipeptide stimulation of particle clearance in several animal species.
Waters RV; Ferraresi RW
J Reticuloendothel Soc; 1980 Nov; 28(5):457-71. PubMed ID: 7441647
[No Abstract] [Full Text] [Related]
13. Epithelioid granuloma formation requiring no T-cell function.
Tanaka A; Emori K; Nagao S; Kushima K; Kohashi O; Saitoh M; Kataoka T
Am J Pathol; 1982 Feb; 106(2):165-70. PubMed ID: 6978073
[TBL] [Abstract][Full Text] [Related]
14. [Epithelioid cell granuloma (author's transl)].
Okabe M; Okuyama H; Morikawa K
Kekkaku; 1980 Oct; 55(10):435-42. PubMed ID: 7014971
[No Abstract] [Full Text] [Related]
15. [Adjuvant activity and adjuvant arthritis].
Tanaka A
Kekkaku; 1980 Oct; 55(10):465-7. PubMed ID: 7230587
[No Abstract] [Full Text] [Related]
16. [Activation of macrophage by bacterial cell wall peptidoglycans and muramyl dipeptides].
Nagao S
Nihon Saikingaku Zasshi; 1987 Nov; 42(6):801-15. PubMed ID: 3448257
[No Abstract] [Full Text] [Related]
17. [Fundamental studies to use the adjuvant activity of 6-o-acylmuramyldipeptides to potentiate cell and humoral immune responses for practical purposes].
Tsujimoto M
J Osaka Univ Dent Sch; 1981 Jun; 26(1):63-83. PubMed ID: 6945426
[No Abstract] [Full Text] [Related]
18. [Chemical synthesis and immunologic activities of the active unit of BCG-CWS].
Saiki I; Azuma I
Nihon Rinsho; 1981 Apr; 39(4):1861-7. PubMed ID: 7031298
[No Abstract] [Full Text] [Related]
19. [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use].
Castrillón LE
Salud Publica Mex; 1987; 29(6):492-9. PubMed ID: 3125614
[No Abstract] [Full Text] [Related]
20. [Potentiation of immune responses to influenza split virus vaccine by synthetic 6-O-acyl-muramylpeptides].
Okunaga T
Osaka Daigaku Shigaku Zasshi; 1980 Jun; 25(1):29-52. PubMed ID: 6935421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
